The new product offerings, which are melatonin free and 100% vegan, bring increased bioavailability of nano-emulsified CBD to consumers, according to the company.
The first generic of Restasis is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.